Experimental Trypanosoma cruzi infection in platelet-activating factor receptor-deficient mice

Microbes and Infection

Volumn 5, Issue 9, 2003, Pages 789-796

  Talvani, André ^a   Santana, Gilcinea ^a   Barcelos, Lucíola S ^a   Ishii, Satoshi ^b   Shimizu, Takao ^b   Romanha, Álvaro J ^c   Silva, João S ^d   Soares, Milena B P ^c   Teixeira, Mauro M ^a,c  

^a FEDERAL UNIVERSITY OF MINAS GERAIS   (Brazil)

^b JAPAN SCIENCE AND TECHNOLOGY AGENCY   (Japan)

^c INSTITUTO OSWALDO CRUZ   (Brazil)

^d UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Chemokines; Inflammation; Knockout; Platelet activating factor; Protozoan infection; TNF

Indexed keywords

ALPHA INTERFERON; GAMMA INTERFERON; IMMUNOGLOBULIN M; LEUKOTRIENE B4; MONOCYTE CHEMOTACTIC PROTEIN 1; NITRATE; NITRIC OXIDE; RANTES; THROMBOCYTE ACTIVATING FACTOR; THROMBOCYTE ACTIVATING FACTOR RECEPTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; FEMALE; GENETIC DISORDER; HEART DISEASE; IN VITRO STUDY; INFLAMMATORY INFILTRATE; KINETICS; LETHALITY; MACROPHAGE; MOUSE; NONHUMAN; PARASITEMIA; PHAGOCYTOSIS; PRIORITY JOURNAL; PROTEIN DEFICIENCY; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTOZOAL INFECTION; TRYPANOSOMA CRUZI; TRYPOMASTIGOTE; WILD TYPE;

ANIMALIA; PROTOZOA; TRYPANOSOMA; TRYPANOSOMA CRUZI;

EID: 0038691616     PISSN: 12864579     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1286-4579(03)00146-1     Document Type: Article

References (30)

1. Dias J.C. Chagas'disease. Epidemiology and prevention. Arq. Bras. Cardiol. 63:1994;451-455.
2. Mendez G.F., Cowie M.R. The epidemiological features of heart failure in developing countries: a review of the literature. Int. J. Cardiol. 80:2001;213-219.
3. Teixeira M.M., Gazzinelli R.T., Silva J.S. Chemokines, inflammation and Trypanosoma cruzi infection. Trends Parasitol. 18:2002;262-265.
4. Teixeira M.M., Almeida I.C., Gazzinelli R.T. Introduction: innate recognition of bacteria and protozoan parasites. Microb. Infect. 4:2002;883-886.
5. Engman D.M., Leon J.S. Pathogenesis of Chagas disease heart disease: role of autoimmunity. Acta Trop. 81:2002;123-132.
6. Soares M.B., Pontes-De-Carvalho L., Ribeiro-Dos-Santos R. The pathogenesis of Chagas' disease: when autoimmune and parasite-specific immune responses meet. An. Acad. Bras. Cienc. 73:2001;547-559.
7. Pontes-de-Carvalho L., Santana C.C., Soares M.B., Oliveira G.G., Cunha-Neto E., Ribeiro-Dos-Santos R. Experimental chronic Chagas' disease myocarditis is an autoimmune disease preventable by induction of immunological tolerance to myocardial antigens. J. Autoimmun. 18:2002;131-138.
8. Brener Z., Gazzinelli R.T. Immunological control of Trypanosoma cruzi infection and pathogenesis of Chagas' disease. Int. Arch. Allergy Immunol. 114:1997;103-110.
9. Coelho P.S., Klein A., Talvani A., Coutinho S.F., Takeuchi O., Akira S., Silva J.S., Canizzarro H., Gazzinelli R.T., Teixeira M.M. Glycosylphosphatidylinositol-anchored mucin-like glycoproteins isolated from Trypanosoma cruzi trypamastigotes induce in vivo leukocyte recruitment dependent on MCP-1 production by IFN-γ-primed-macrophages. J. Leuk. Biol. 71:2002;837-844.
10. dos Santos P.V., Roffe E., Santiago H.C., Torres R.A., Marino A.P., Paiva C.N., Silva A.A., Gazzinelli R.T., Lannes-Vieira J. Prevalence of CD8 (+) alpha beta T cells in Trypanosoma cruzi-elicited myocardites is associated with acquisition of CD62L (low) LFA-1 (high) VLA-4 (high) activation phenotype and expression of IFN-gamma-inducible adhesion and chemoattractant molecules. Microb. Infect. 3:2001;971-984.
11. Talvani A., Ribeiro C.S., Aliberti J.C.S., Michailowsky V., Santos P.V., Murta S.M., Romanha A.J., Almeida I.C., Farber J., Lannes-Vieira J., Silva J.S., Gazzinelli R.T. Kinetics of cytokine gene expression in experimental chagasic cardiomyopathy: tissue parasitism and endogenous IFN-gamma as important determinants of chemokine mRNAs expression during infection with Trypanosoma cruzi. Microb. Infect. 2:2000;851-866.
12. 4 induces nitric oxide synthesis in Trypanosoma cruzi-infected murine macrophages and mediates resistance to infection. Infect. Immun. 70:2002;4247-4253.
13. Villalta F., Zhang Y., Bibb K., Kappes J.C., Lima M.F. The cysteine- cysteine family of chemokines RANTES, MIP-1 alpha and MIP-1 beta induce trypanocidal activity in human macrophages via nitric oxide. Infect. Immun. 66:1998;4690-4695.
14. Braquet P., Touqui L., Shen T.Y., Vargaftig B.B. Perspectives in platelet-activating factor research. Pharmacol. Rev. 39:1987;97-145.
15. Montrucchio G., Alloatti G., Camussi G. Role of platelet-activating factor in vascular cardiovascular pathophysiology. Physiol. Rev. 80:2000;1669-1699.
16. Klein A., Pinho V., Alessandrini A.L., Shimizu T., Ishii S., Teixeira M.M. Platelet-activating factor drives eotaxin production in an allergic pleurisy in mice. Br. J. Pharmacol. 135:2002;1213-1218.
17. Aliberti J.C.S., Machado F.S., Souto J.T., Campanelli A.P., Teixeira M.M., Gazzinelli R.T., Silva J.S. β-chemokines enhance parasite uptake and promote nitric oxide-dependent microbiostatic activity in murine inflammatory macrophages infected with Trypanosoma cruzi. Infect. Immun. 67:1999;4819-4826.
18. Martins G.A., Vieira L.Q., Cunha F.Q., Silva J.S. Gamma Interferon modulates CD95 (Fas) and CD95 ligand (Fas-L) expression and nitric oxide-induced apoptosis during the acute phase of Trypanosoma cruzi infection: a possible role in immune response control. Infect. Immun. 67:1999;3864-3871.
19. Aliberti J.C.S., Machado F.S., Gazzinelli R.T., Teixeira M.M., Silva J.S. Platelet-activating factor induces nitric oxide synthesis in Trypanosoma cruzi-infected macrophages and mediates resistance to parasite infection in mice. Infect. Immun. 67:1999b;2810-2814.
20. Ishii S., Shimizu T. Platelet-activating factor (PAF) receptor and genetically engineered PAF receptor mutant mice. Prog. Lipid. Res. 39:2000;41-82.
21. Melo R.C., Brener Z. Tissue tropism of different Trypanosoma cruzi strains. J. Parasitol. 64:1978;475-482.
22. Vespa G.N.R., Cunha F.Q., Silva J.S. Nitric oxide is involved in control of Trypanosoma cruzi-induced parasitemia and directly kills the parasite in vitro. Infect. Immun. 62:1994;5177-5182.
23. Tavares-Murta B.M., Zaparoli M., Ferreira R.B., Silva-Vergara M.L., Oliveira C.H., Murta E.F., Ferreira S.H., Cunha F.Q. Failure of neutrophil chemotactic function in septic patients. Crit. Care M. 30:2002;1056-1061.
24. Jackson J.R., Bolognese B., Mangar C.A., Hubbard W.C., Marshall L.A., Winkler J.D. The role of platelet activating factor and other lipid mediators in inflammatory angiogenesis. Biochim. Biophys. Acta. 1392:1998;145-152.
25. Honda Z., Ishii S., Shimizu T. Platelet-activating factor receptor. J. Biochem. 131:2002;773-779.
26. Souza D.G., Cara D.C., Cassali G.D., Coutinho S.F., Silveira M.R., Andrade S.P., Poole S., Teixeira M.M. Effects of the PAF receptor antagonist UK74505 on local and remote reperfusion injuries following ischemia of the superior mesenteric artery in the rat. Br. J. Pharmacol. 131:2000;1800-1808.
27. Au B.T., Teixeira M.M., Collins P.D., Williams T.J. Blockade of PAF receptors controls IL-8 production by regulating the activation of neutrophil CD11/CD18. Eur. J. Pharmacol. 425:2001;65-71.
28. Aliberti J.C.S., Souto J.T., Marino A.P.M., Lannes-Vieira J., Teixeira M.M., Farber J., Gazzinelli R.T., Silva J.S. Modulation of chemokine production and inflammatory responses in interferon-γ and tumor necrosis factor-R1-deficient mice during Trypanosoma cruzi infection. Am. J. Pathol. 158:2001;1433-1440.
29. Machado F.S., Martins G.A., Aliberti J.C.S., Mestriner F.L.A.C., Cunha F.Q., Silva J.S. Trypanosoma cruzi-infected cardiomyocytes produce chemokines and cytokines that trigger potent nitric oxide-dependent Trypanocidal activity. Circulation. 102:2000;3003-3008.
30. Marrache A.M., Gobeil F. Jr., Bernier S.G., Stankova J., Rola-Pleszczynski M., Choufani S., Bkaily G., Bourdeau A., Sirois M.G., Vazquez-Tello A., Fan L., Joyal J.S., Filep J.G., Varma D.R., Ribeiro-Da-Silva A., Chemtob S. Proinflammatory gene induction by platelet-activating factor mediated via its cognate nuclear receptor. J. Immunol. 169:2002;6474-6481.